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T he present review will describe some of the more recent developments in 
the clinical utilization of knowledge con- 
cerning renin and angiotensin acquired in 
the last two years. It is not intended to be 
all inclusive or to review information pub- 
lished prior to 1967, by which time several 
excelbent summaries of current knowledge 
in this field were published.r-7 Furthermore, 
the extensive developments in the method- 
ology of renin and angiotensin assays will 
not bme discussed, since the purpose is to 
present the clinician with the physiologi- 
cal background and recently accumulated 
knowledge concerning the renin-angiotensin 
system in clinical situations. 
Thle well-known relationships are sum- 
marized in the following equations: 
+ Activators 
cu-glob,.Gn Renin - Inhibitors 
sL.bstrate - Angiotensin I 
(decapeptide) 
Converting enzyme 
Angiolzensin I - Angiotensin II 
(octapeptide) 
Angiol:ensin II - - Inactive 
Tissue peptidases peptides 
The first reaction is ordinarily considered 
to be the rate-limiting one. Angiotensin II 
is the significant product: It is a vasocon- 
strictor, evokes aldosterone secretion, and 
thus leads to sodium retention. It is rapidly 
destroyed in the capillary circulation by 
tissue angiotensinases. Since the a-globulin 
substrate is usually in excess and convert- 
ing enzyme is ubiquitous, renin is the sig- 
nificant precursor. It is secreted by the 
kidney apparently in response to a de- 
creased tubular sodium load. Because of 
its large molecular size, it remains in cir- 
culating plasma for some time (half-life, 
4.5 minutes after binephrectomy).* It is 
measured by the amount of angiotensin 
it produces under suitable conditions of 
incubation. Since inhibitors or activators 
of the enzyme are almost certainly present 
in plasma, it should be stressed that assays 
for renin include the effects of such co- 
enzymes or even of modifications of sub- 
strate. Hence the term plasma renin-like 
activity (PRA) will be used in the discus- 
sion that follows. 
The physiological role of renin has been 
the subject of much speculation. The origi- 
nal concept that its;purpose was to regulate 
perfusion pressure to the kidney whose 
renal artery was obstructed has been re- 
placed by the broaderi’hji’p&hesis that it is 
the primary’ stimulus for maintenance of 
body sodium balance. The support’for this 
theory cannot be - detailed:: here, but it 
seems attractive to these reviewers since 
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it explains well the two classical conditions 
in which PRA is increased: (1) when there 
is a decreased renal perfusion pressure, and 
(2) when there is a decreased delivery of 
sodium and water to the macula densa cell 
in the distal tubule. In the former instance 
(renal artery stenosis, systemic hypoten- 
sion, afferent renal arteriolar vasoconstric- 
tion from blood loss, upright posture, or 
malignant hypertension), there is inevi- 
tably a decrease in filtration of sodium and 
water at the glomerulus and thereby a 
probable decrease in the arnount of sodium 
delivered to the distal tubule where macula 
densa cells may serve as the sensing 
mechanism. Decreased sodium delivery to 
the distal tubules probably also occurs 
without an obvious change in renal hemo- 
dynamics during dietary salt restriction 
and in certain disease states associated 
with sodium retention. Decreased PRA is 
seen in contrary circumstances : increased 
renal perfusion pressure, expanded plasma 
volume, and salt loading. 
PRR may also increase as a result of 
direct hormonal or pharmacologic effects 
perhaps altering the permeability of the 
macula densa cell to sodium (furosemide). 
There must likewise be a feedback control 
mechanism to reduce PRA. Although little 
is known, it does seem clear that angio- 
tensin infusions reduce PRA.g 
Renin-angiotensin in blood @ressure regu- 
lation: inhibitors and activators. The many 
conditions in which renin is secreted in 
excess and in which blood pressure remains 
normal cast doubt on the direct role of 
renin in blood pressure regulation; if it is 
significant in the causation of essential or 
renovascular hypertension, an as yet un- 
known factor must coexist. Renin antibody 
infused intravenously will not lower blood 
pressure in the hypertensive animallO; the 
plasma level of renin in chronic Goldblatt 
hypertension is normal,llJ” and when it is 
found to be elevated in experimental 
hypertension, the explanation usually lies 
in a physiologic situation in which the 
kidney needs to retain salt and water.r3 
It is entirely possible that the relation 
of renin to hypertension may be through 
the release of angiotensin at vascular re- 
ceptors. Since this polypeptide is rapidly 
removed by tissue angiotensinases, its 
level in peripheral blood may not rellect its 
vasoconstrictor activity at the locus of the 
arteriole, just as circulating norepineph- 
sine is an inadequa.te reflection of the 
sympathetic nerve release of norepineph- 
rine at receptor sites. Activators or inhibi- 
tors of renal and endocrine origin may 
affect the rate of angiotensin production 
without changing the level of circulating 
renin. We have recently demonstrated that 
the rise in blood pressure occurring after 
ablation of a normal kidney in an animal 
with a unilateral renal artery clip is 
associated with a marked increase in the 
rate of angiotensin generation in vitro.‘* 
Furthermore, such increased angiotensin 
generation and the concomitant enhanceb 
pressor response to renin seen after di- 
nephrectomy is inhibited by normal renal 
medul1a.r” Finally, in the experimental 
hypertensive animal a renin inhibitor has 
been described which when injected lowers 
the blood pressure to normal.‘” 
After nephrectomy, angiotensin, pre- 
sumably derived from a nonrenal source of 
renin or by the action of a like enzyme 
perhaps rendered more apparent by the 
absence of a renal inhibitor, reappears in 
blood.r7 Uterine tissue and salivary gland 
have been shown to contain renin.18-20 
Arteries themselves exhibit some renin-like 
activity.21 
Some experimental observations concerning 
the mechanism of renin release. Although 
most of the experiments to be cited in this 
section were made prior to the period cov- 
ered by the present review, some of the 
more pertinent observations will be dis- 
cussed at this point. 
The macula densa theory, that sodium 
delivery to the distal tubule is the control- 
ling factor in renin release, now has wide 
acceptance but some discrepancies remain. 
It is probably not distal tubular sodium 
concentration but total sodium delivery 
which is the important signal. Micro- 
puncture studies have indeed shown that 
distal tubular sodium concentration changes 
very slightly and unpredictably during 
maneuvers producing a reduction in renal 
artery perfusion pressure; however, the 
total sodium load presented to the distal 
tubular ccl: is always substantially re- 
duced in these states. A further difficulty 
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with acceptance of the macula densa theory 
concerns the response to furosemide. The 
increased tubular sodium delivery follow- 
ing administration of furosemide, occurring 
at the onset of diuresis and without change 
in total body sodium, has been shown to be 
associated with an increase in PRA.2” 
Vander6 has postulated that the macula 
densa cells may accumulate sodium in- 
ternally in relation to the amount previ- 
ously presented to them in the tubular 
lumen. The paradox which occurs during 
furosemide diuresis without change in 
salt balance, he suggests, is caused by the 
action of certain diuretics in reducing the 
permeability of the wall of the macula 
densa. cell to this sodium influx.23 
The assumption that the macula densa 
cell signals the juxtaglomerular (JG) cells 
to relmease renin has good theoretical sup- 
port. The unusual orientation of the 
cytoplasmic constituents and the special 
permeability of the interface between 
macula densa cell and the JG cell support 
this theory,’ and it is even possible that 
renin itself may also be elaborated in the 
macu1.a densa ce11.24 
The baroreceptor hypothesis was based 
mainly on the experiments of Skinner, 
McCubbin, and Page,25 who have shown 
that renin release occurred with very slight 
reductions in mean arterial pressure (10 
mm. Hg). The same authors observed that 
renin release is not dependent on pulse 
pressure, since a combination of aortic 
constriction and vagotomy (which virtually 
abolish the pulse pressure without changing 
the mean arterial pressure) fails to stimu- 
late renin secretion. It would appear, at 
first glance, that this theory cannot explain 
the increased or decreased renin release 
observed in those circumstances that are 
not iaccompanied by the corresponding 
changes in renal arterial pressure, as, for 
example, during salt deprivation or sodium 
loading.26 However, changes in the renal 
arterial pressure do not necessarily produce 
similar directional changes in the glomeru- 
lar aiyerent arteriole or in its transmural 
pressure. Consequently, the variation of 
transmural pressure cannot be easily pre- 
dicted or measured and it may be the 
controlling influence on JG cell activity. 
However, such a theory would not explain 
the intimate relation between i;hese cells 
and the macula densa. 
Another factor to be considered is the re- 
lation of the sympathetic nervous systemz7 
and catecholamines28 to renin secretion. 
While many of their effects can be explained 
by afferent renal arteriolar vasoconstriction 
and/or decreased sodium delivery to the 
distal tubule, some effects when cate- 
cholamines are applied directly to JG cells 
may require invoking an unknown mech- 
anism of action.2g 
Clinical observations: 196s to 1969. 
In Table I most of the publications de- 
voted to renin measurements in the human 
being which appeared during 1968, and up 
to April, 1969, are summarized. They will 
be considered under the appropriate head- 
ings. The discussion which follows will 
attempt to relate these observations to the 
macula densa theory of renin release or 
inhibition. 
Physiologic and pharmacologic stimuli. 
Agents which deplete plasma volume or 
decrease glomerular filtration rate (GFR) 
lead to a decrease in exposure of macula 
densa cells to sodium and hence excite 
renin release as a measure to preserve 
body sodium and total body fluids. Thus 
the effect of dietary sodium depletion is to 
elevate PRA.26,30 Thiazide diuretics act 
similarly, but after the steady state of salt 
depletion is reached, the amount of sodium 
passing through the renal tubules is equal 
to that in the diet. Accordingly, it is seen 
that chronic thiazide treatment is not 
associated with elevated plasma renin 
unless the patient also remains on a low 
sodium intake.31 
Stimulation of sympathetic innervation 
to the kidney is known to produce afferent 
arteriolar vasoconstriction, decreased GFR, 
and a lessened sodium delivery to the 
distal tubule. Hence it is not surprising to 
learn that upright posture,28 apprehension,32 
cold pressor stimulation,2s and catechol- 
amine infusionz8 cause high renin levels, 
while reserpine33 and clonidine hydro- 
chloride (Catapres) 34 decrease the blood 
Ievels of this enzyme. Hydralazine35 reduces 
blood pressure and acutely increases renal 
blood flow but does not increase GFR. 
Thus distal tubular sodium delivery may 
not be elevated. In any event this drug, 
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Table I. Recent re;borts on the renin-angiotensin system in various conditions in man* 
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Cirrhosis with edema t . 45 
PRA: + = increased; - = decreased; 0 = no change. 
DOC = desox-ycorricosterone. 
*Drawn in most part from the medical literature, 1968 to 1969. 
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like sodium nitroprusside3’j which also 
lowers systemic blood pressure, increases 
renin release. 
Certain compounds have effects on 
plasma renin which are as yet poorly ex- 
plained: Furosemidez2 appears to act di- 
rectly, perhaps altering the permeability 
of the macula densa cell to sodium ; adrenal 
cortical substances3’ and oral contracep- 
tives? raise “substrate” levels, but their 
influence on PRA results in no change or a 
slight increase38; the results may turn out 
to be due to the appearance of an activator 
of the renin-angiotensin reaction discussed 
in an earlier portion of this review, and 
this is almost certainly the explanation of 
the situation after nephrectomy in the 
experimental animal.15 
Pregnancy. Pregnancy has assumed spe- 
cial interest. PRA rises,3g,40 but less so in 
toxemia.40 The amniotic fluid and the 
chorion also contain renin-like activity.41r42 
The high PRA levels persist after de- 
livery3g; hence the excess enzyme is not of 
fetal origin but is probably derived from 
the hypertrophied uterus. In this con- 
nection it is interesting that females but 
not males exhibit measurable renin ac- 
tivity after nephrectomy.17 Thus the uterus 
appears to provide a nonrenal source for 
renin in woman. PRA responds to the 
usual stimulation43 in pregnancy. 
Renal diseases. The variable findings in 
renal diseases are probably related to the 
tubular sodium load obtained in these con- 
ditions. In chronic glomerulonephritis45 
where this is presumably normal, PRA is 
not elevated, and it varies in nephrosis 
depending on the state of edema; PRA is 
elevated when sodium is being retained 
and falls to normal after diuresis.45 In the 
anephric individual PRA fallslr,46 but 
rises again with transplantation and re- 
sponds normally to physiologic stimuli 
(thus presumably excluding nervous con- 
nections as the intermediary for this in- 
fluence).47r48 Obstructive uropathy has been 
little studied, but in one case with hyper- 
tension subsequently cured by surgery, 
PRA was elevated in the renal vein blood 
of the obstructed kidney.4g 
Hypertension. The situation in reno- 
vascular hypertension has been widely 
studied. Systemic PRA has not been shown 
to be constant1.y elevated in cases of 
renovascular hypertension; however, in 
the majority of cases the peripheral samples 
are above norma1,46*50-52 particularly after 
appropriate stimulation5” Perhaps the de- 
gree to which one or both kidneys is de- 
prived of sodium flux at the level of the 
macula densa determines this variability. 
The extensive literature on this subject 
prior to the review period should be con- 
sulted.l-’ The recent review by Del Greco 
and co-authors50 is particularly helpful in 
understanding this important but difficult 
topic. The difference in renin concentration 
from the renaI veins is agreed to be diag- 
nostic of a significant unilateral renal 
artery stenosis.*46,53-57 This test is at least 
as reliable as the split function tests pre- 
viously used. 57 A high renal vein concentra- 
tion alone, not accompanied by an ade- 
quate renal blood flow, may account in 
some cases for false positive results. If 
systemic or vena caval samples taken from 
above the renal veins are high, this sup- 
ports the proba.bility of a high secretion 
rate and therefore of a potentially curable 
lesion.58 
Patients with essential hypertension by 
contrast show in some cases a reduced 
PRA possibly because in this condition 
there is a reduced tubular sodium reabsorp- 
tion and therefore an increased sodium 
load to the macula densa. The response to 
stimulation is sluggish, and approximately 
25 per cent of hypertensive patients with 
normal plasma volumes and normal aldo- 
sterone excretion have a subnormal rise in 
PRA after stimulation.5gz60 In coarctation 
PRA is normal.61 
Endocrine disorders. As we have men- 
tioned, numerous endocrine secretions af- 
fect the renin-angiotensinogen reaction 
rate which may be reflected in an apparent 
increase in PRA.37*38 In primary aldo- 
steronism there is an increased extra- 
celluIar fluid volume and consequently a 
low level of PRA is seen.@ The same applies 
to licorice hypertension,63 the clinical 
analogue of desoxycorticosterone acetate 
*In our experience and in that of Hunt and associates,~~ the 
differences are accentuated by prior postural and sodium- 
depleting stimuli. The differences are rapidly accentuated 
on assuming the upright posture but may be obscured by 
reassuming, recumbency.6~ 
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hypertension in which the resting PRA is 
also low. In Bartter’s syndromeG4 of JG 
cell hyperplasia high renin levels are the 
result of autonomously high secretion 
rates. In a curious hypertensive condition 
described by Laragh and colleagues,65 low 
PRA is associated with high aldosterone 
secretion, but the blood pressure does not 
decline following adrenalectomy and no 
adrenal adenomas were found. In pheo- 
chromocytoma,@ PRA is elevated, prob- 
ably through the intervention of the 
sympathomimetic secretions on renal blood 
flow. 
Congenital adrenal hyperplasia (CAH) 
is a disorder of adrenal steroid biosynthesis. 
The defect in steroid synthesis has been 
shown to be due to a block of 21-hydroxy- 
lation. In the salt-losing form of the dis- 
ease there is a good deal of evidence indi- 
cating a diminished synthesis of aldo- 
sterone. Consequently, approximately 30 
per cent of individuals with CAH are 
unable to retain sodium and frequently 
develop some dehydration. Godard and 
co-workers”’ measured PRA and aldo- 
sterone secretion rates in 7 patients ranging 
from 5 months to 12 years of age. They 
found a distinct increase of PRA in 60 per 
cent of the cases while on a liberal salt 
intake. Salt restriction produced a marked 
increase in PRA but a less than normal 
increase in aldosterone secretion. They 
concluded that, at least in the salt-losing 
form of the condition, there was a dirnin- 
ished synthesis of aldosterone and perhaps 
also an angiotensin-induced natriuresis. 
In this condition, compensatory hyper- 
trophy of the JG cells has been found by 
Cara and Gardner.68 
Imai and associates69 obtained similar 
results in two patients with the salt-losing 
form of congenital virilizing adrenal hyper- 
plasia. In one case of the hypertensive 
form of the disease, where there is de- 
ficiency of 11 -hydroxylase production which 
leads to formation of desoxycorticosterone 
and to sodium retention, PRA was reported 
to be depressed. 
Conclusions 
The clinical data are, in general, con- 
sistent with the theory that renin release 
varies inversely with the tubular sodium 
!oad. Many dpparenr ciirxlcai paradoxes 
are explained when the intimate changes 
in renal sodium handling under diverse 
physiologic, pharmacologic, and disease 
states are related to the effect on tubular 
sodium delivery. Some discrepancies re- 
main which may be related to less under- 
stood influences on the macula densa cell. 
Subjects for fruitful clinical research 
would include studies of the effects of in- 
bibitors and activators on the renin-angio- 
tensin system and an explanation of the 
Low level and sluggish response of renin 
seen in some subjects with essential hyper- 
tension. 
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